$23.17
0.56[2.48%]
At close: Apr 26
$23.17
0[0.00%]
After Hours: 4:20PM EDT
AtriCure
(NASDAQ:ATRC)AtriCure Stock (NASDAQ:ATRC), Analyst Ratings, Price Targets, Predictions
AtriCure Inc has a consensus price target of $54.7, established from looking at the 45 latest analyst ratings. The last 3 analyst ratings were released from Oppenheimer, Needham, and UBS on April 23, 2024, April 10, 2024, and February 16, 2024. With an average price target of $45.33 between Oppenheimer, Needham, and UBS, there's an implied 95.66% upside for AtriCure Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Oppenheimer
Needham
UBS
Stifel
JMP Securities
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for AtriCure
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/23/2024 | ATRC | Buy Now | AtriCure | $23.17 | 38.11% | Oppenheimer | Suraj Kalia | → $32 | Upgrade | Perform → Outperform | Get Alert |
| 04/10/2024 | ATRC | Buy Now | AtriCure | $23.17 | 98.53% | Needham | Mike Matson | → $46 | Reiterates | Buy → Buy | Get Alert |
| 02/16/2024 | ATRC | Buy Now | AtriCure | $23.17 | 150.32% | UBS | Danielle Antalffy | $57 → $58 | Maintains | Buy | Get Alert |
| 02/16/2024 | ATRC | Buy Now | AtriCure | $23.17 | 81.27% | Stifel | Rick Wise | $50 → $42 | Maintains | Buy | Get Alert |
| 02/16/2024 | ATRC | Buy Now | AtriCure | $23.17 | 98.53% | Needham | Mike Matson | $44 → $46 | Maintains | Buy | Get Alert |
| 01/04/2024 | ATRC | Buy Now | AtriCure | $23.17 | 89.9% | Needham | Mike Matson | $49 → $44 | Maintains | Buy | Get Alert |
| 11/29/2023 | ATRC | Buy Now | AtriCure | $23.17 | 158.96% | JMP Securities | Daniel Stauder | → $60 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 11/29/2023 | ATRC | Buy Now | AtriCure | $23.17 | 111.48% | Needham | Mike Matson | → $49 | Reiterates | Buy → Buy | Get Alert |
| 11/02/2023 | ATRC | Buy Now | AtriCure | $23.17 | 115.8% | JP Morgan | Robbie Marcus | $60 → $50 | Maintains | Overweight | Get Alert |
| 11/02/2023 | ATRC | Buy Now | AtriCure | $23.17 | 111.48% | Needham | Mike Matson | $68 → $49 | Maintains | Buy | Get Alert |
| 10/23/2023 | ATRC | Buy Now | AtriCure | $23.17 | 158.96% | JMP Securities | Daniel Stauder | → $60 | Initiates | → Market Outperform | Get Alert |
| 09/29/2023 | ATRC | Buy Now | AtriCure | $23.17 | 141.69% | UBS | Danielle Antalffy | → $56 | Initiates | → Buy | Get Alert |
| 07/26/2023 | ATRC | Buy Now | AtriCure | $23.17 | 193.48% | Needham | Mike Matson | $60 → $68 | Maintains | Buy | Get Alert |
| 06/02/2023 | ATRC | Buy Now | AtriCure | $23.17 | 158.96% | Needham | Mike Matson | → $60 | Reiterates | Buy → Buy | Get Alert |
| 05/03/2023 | ATRC | Buy Now | AtriCure | $23.17 | 158.96% | Needham | Mike Matson | $58 → $60 | Maintains | Buy | Get Alert |
| 04/17/2023 | ATRC | Buy Now | AtriCure | $23.17 | 150.32% | Needham | Mike Matson | → $58 | Maintains | Buy | Get Alert |
| 02/22/2023 | ATRC | Buy Now | AtriCure | $23.17 | 137.38% | BTIG | Marie Thibault | $65 → $55 | Maintains | Buy | Get Alert |
| 02/22/2023 | ATRC | Buy Now | AtriCure | $23.17 | 107.16% | Stifel | Rick Wise | $55 → $48 | Maintains | Buy | Get Alert |
| 02/22/2023 | ATRC | Buy Now | AtriCure | $23.17 | 219.38% | Canaccord Genuity | William Plovanic | $81 → $74 | Maintains | Buy | Get Alert |
FAQ
What is the target price for AtriCure (ATRC)?
The latest price target for AtriCure (NASDAQ: ATRC) was reported by Oppenheimer on April 23, 2024. The analyst firm set a price target for $32.00 expecting ATRC to rise to within 12 months (a possible 38.11% upside). 15 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for AtriCure (ATRC)?
The latest analyst rating for AtriCure (NASDAQ: ATRC) was provided by Oppenheimer, and AtriCure upgraded their outperform rating.
When was the last upgrade for AtriCure (ATRC)?
The last upgrade for AtriCure Inc happened on April 23, 2024 when Oppenheimer raised their price target to $32. Oppenheimer previously had a perform for AtriCure Inc.
When was the last downgrade for AtriCure (ATRC)?
The last downgrade for AtriCure Inc happened on August 5, 2021 when Oppenheimer changed their price target from N/A to N/A for AtriCure Inc.
When is the next analyst rating going to be posted or updated for AtriCure (ATRC)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of AtriCure, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for AtriCure was filed on April 23, 2024 so you should expect the next rating to be made available sometime around April 23, 2025.
Is the Analyst Rating AtriCure (ATRC) correct?
While ratings are subjective and will change, the latest AtriCure (ATRC) rating was a upgraded with a price target of $0.00 to $32.00. The current price AtriCure (ATRC) is trading at is $23.17, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.